What is BLZE's health score?

Backblaze, Inc. (BLZE) has a TradeApes health score of 51 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BLZE's estimated fair value?

Based on our 5-year discounted cash flow model, Backblaze, Inc.'s estimated fair value is $5.88 per share, representing a -29.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BLZE undervalued or overvalued?

Our model currently rates BLZE as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BLZE... Refresh in a moment for the full analysis.

Backblaze, Inc. (BLZE)

Technology Undervalued low mixed

$8.38

Updated: 2026-06-04

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

66 Healthy

Relative Value

50 Mixed

Capital Allocation

10 Stressed

Risk

50 Mixed

Est. Fair Value $5.88

DCF Upside -29.9%

Sector Rank #4255 of 7838

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.